$ACAD Recent News This tiny mutual fund is no. 1 for 2013

New Post Public Reply Private Reply Replies (0) Message Board

Mar 7, 2014 at 12:08 PM

$ACAD Recent News

This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Despite Fed concerns, technicals support bull case 1:16 p.m. Sept. 17, 2013 - Michael Ashbaugh
Despite Fed concerns, technicals support bull case 12:02 p.m. Sept. 17, 2013 - Michael Ashbaugh
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
Charting the S&P 500’s break to all-time highs 11:47 a.m. Aug. 6, 2013 - Michael Ashbaugh
Longer-term technical risk points higher 11:32 a.m. Aug. 6, 2013 - Michael Ashbaugh
7 gut checks before the stock market's opening bell 5:56 a.m. July 30, 2013 - Shawn Langlois
Charting a strong third-quarter start 11:23 a.m. July 16, 2013 - Michael Ashbaugh
Charting a strong third-quarter start 11:17 a.m. July 16, 2013 - Michael Ashbaugh
Looking for the choicest opportunity 12:37 p.m. June 11, 2013 - The Trading Deck
Declines often spell opportunity 1:11 p.m. June 6, 2013 - The Trading Deck
Don't fight the tape 10:27 a.m. May 28, 2013 - The Trading Deck
Charting the S&P’s uptrend, and its next hurdle 10:55 a.m. April 23, 2013 - Michael Ashbaugh
Charting the S&P’s uptrend, and its next hurdle 10:25 a.m. April 23, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Dow, S&P pull in from record highs 10:15 a.m. April 12, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 11:01 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 10:50 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 vies for record closing high 11:19 a.m. March 28, 2013 - Michael Ashbaugh
Acadia Pharma up 10% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi

Today's Perilous Reversal Stock: ACADIA Pharmaceuticals (ACAD) 9:45 a.m. March 5, 2014 - TheStreet.com
Morning Lowers for Mar. 5, 2014: XOMA, USU, CSIQ, AUDC, RATE 9:14 a.m. March 5, 2014 - benzinga.com
ACADIA Pharmaceuticals Announces $150M Proposed Public Offering of Common Stock 3:01 p.m. March 3, 2014 - benzinga.com
An Update On Acadia Pharmaceuticals 9:34 a.m. March 1, 2014 - Seeking Alpha
Cynapsus Represents A Compelling Acquisition Target For Acadia Pharmaceuticals 2:04 p.m. Feb. 28, 2014 - Seeking Alpha
ACADIA Pharmaceuticals (ACAD) Is Water-Logged And Getting Wetter Today 11:55 a.m. Feb. 28, 2014 - TheStreet.com
ACADIA Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript 8:50 p.m. Feb. 27, 2014 - Seeking Alpha
More on Acadia results 4:27 p.m. Feb. 27, 2014 - Seeking Alpha
10-K: ACADIA PHARMACEUTICALS INC 4:19 p.m. Feb. 27, 2014 - Edgar Online - (EDG = 10Q, 10K)
ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% - Tale of the Tape 9:18 a.m. Feb. 24, 2014 - Zacks.com
Watch Out: Barbarians At The Gate For ACADIA Pharmaceuticals (ACAD) 11:19 a.m. Feb. 21, 2014 - TheStreet.com
Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming 8:31 a.m. Feb. 11, 2014 - Seeking Alpha
Commit To Purchase Acadia Pharmaceuticals At $15, Earn 17.9% Annualized Using Options 12:00 p.m. Feb. 5, 2014 - TheStreet.com
Cramer's Lightning Round - Archer Daniels Midland Is Much Ado About Nothing (1/30/14) 6:22 a.m. Jan. 31, 2014 - Seeking Alpha
'Mad Money' Lightning Round: Don't Bet on Boyd Gaming 6:00 a.m. Jan. 31, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Social, Mobile, Cloud Are Buys 8:19 p.m. Jan. 30, 2014 - TheStreet.com
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) 5:16 a.m. Jan. 29, 2014 - Seeking Alpha
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Jan. 28, 2014 - Seeking Alpha
Notes From One-On-One Meetings During San Fran Biotech Week - Day 1 9:05 a.m. Jan. 23, 2014 - Seeking Alpha
Acadia slides as SA article paints grim picture 12:39 p.m. Jan. 7, 2014 - Seeking Alpha

ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences 6:00 a.m. March 5, 2014 - BusinessWire - BZX
ACADIA Pharmaceuticals Prices Public Offering of Common Stock 7:29 p.m. March 4, 2014 - BusinessWire - BZX
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock 4:02 p.m. March 3, 2014 - BusinessWire - BZX
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013 4:03 p.m. Feb. 27, 2014 - BusinessWire - BZX
Critical Alerts For Microsoft, GlaxoSmithKline, SunEdison, Acadia, and Family Dollar Released By InvestorsObserver 9:31 a.m. Feb. 27, 2014 - PR Newswire - PRF
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2013 Financial Results on February 27, 2014 9:01 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch 8:00 a.m. Dec. 25, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola 8:00 a.m. Nov. 29, 2013 - PR Newswire
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 26, 2013 - BusinessWire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
Earnings, Trend Analysis: The Dow Chemical, Turquoise Hill Resources, ACADIA Pharmaceuticals, E Commerce China Dangdang, Yum! Brands 9:35 a.m. Nov. 15, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis 9:00 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:29 a.m. Nov. 7, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:01 p.m. Nov. 6, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Publication in The Lancet of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin 7:40 p.m. Oct. 31, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Gala Spotlights Veterans' Mental Health Support

Champions for Veterans Honored at Headstrong Gala If you ever wondered who stands in the trenches alongside veterans facing mental health battles, this year's Headstrong Gala offered a crystal-clear answer. Held on October 16 at Pier Sixty in New York City, this shiindig wasn’t just about schmoozing over canapés. It was about celebrating the grit and guts of those...

Navigating Home Sales: Expert Insights from Jodi Kallus

Preparing for the Real Estate Rollercoaster Getting ready to sell your home? Let's cut through the noise and get right into the nitty-gritty with Jodi Kallus, a seasoned real estate pro with Summit Realtors. The first step ain't just about slapping a ‘For Sale’ sign on your front lawn. It's about laying down a plan that's as solid as the foundation of the house you're...

Infosys Pushes AI Growth with Strong Deal Wins

Riding the AI Wave Who knew Infosys was a lightning rod for AI momentum, eh? With a 29% quarterly surge in AI revenue, the firm's really putting AI strategy at center stage. Considering today's finicky markets, that's not just peanuts. CEO Salil Parekh's swagger is backed by real numbers, seeing AI revenue inch to 10.5% of total haul. This ain't just talk—Infosys is...

Ping An Good Doctor Grows 35%: AI's Expanding Role

Ping An Good Doctor's Noteworthy Financial Uptick Stop me if you've heard this one: a hefty hike in numbers that make investors straighten up a bit. Ping An Good Doctor did just that, reporting a 35% spark in net profit as the books closed up till September 2026. In a landscape where many health-tech firms merely tread water, these guys rode a wave of RMB 0.25 billion in...

Palmstreet Amplifies Designer Toys at Las Vegas Con

Designer Toys Take the Spotlight Palmstreet's latest move into the designer toy world is buzzing with anticipation. This live-shopping app, initially catering to rare plants, is taking its evolution seriously with another plunge into exclusive collectibles, this time showcasing unique collaborations at DesignerCon in Las Vegas. While Palmstreet may have started in a...

Lincoln Educational Faces Investor Lawsuit Over Revenue Drop

Investors Face Rough Waters Okay, let’s dive into this latest mess at Lincoln Educational Services Corp. (NASDAQ:LINC). Things aren't smelling too rosy over at their headquarters. If you've got shares here, you’ll know what I mean. Back in early May, the folks running Lincoln threw a garden party talking up a 19.5% growth in student starts. Who wouldn’t get behind...

Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

S&P Global's New Dashboard: Unpacking Data Insights

An Interactive Take on Digital Infrastructure The geniuses over at S&P Global Ratings have just unleashed a shiny new tool for number crunchers and market hawks who can't get enough data center action—an interactive dashboard. Maybe not everyone’s cup of tea, but hey, in the dog-eat-dog world of digital infrastructure, any edge counts. What's in the Data Center Soup?...

Patrick Ta Beauty Adds New Leadership to Expand Growth

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...